Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cameron, L. D.
Right arrow Articles by Patrick-Miller, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cameron, L. D.
Right arrow Articles by Patrick-Miller, L. J.
Related Collections
Right arrow Musculoskeletal
Right arrow Personality

Trait Anxiety and Tamoxifen Effects on Bone Mineral Density and Sex Hormone- Binding Globulin

Linda D. Cameron, PhD, Howard Leventhal, PhD, Richard R. Love, MD and Linda J. Patrick-Miller, PhD

From the Department of Psychology (L.D.C.), Faculty of Science, University of Auckland, Auckland, New Zealand; Rutgers—The State University of New Jersey (H.L., L.J.P-M.), New Brunswick, New Jersey; and University of Wisconsin (R.R.L.), Madison, Wisconsin.



View larger version (11K):

[in a new window]
 
Fig. 1. Relationship between BMD of the lumber spine assessed at 24 months post-baseline and trait anxiety (assessed at baseline) for women receiving 10 mg of tamoxifen (N = 59) and women receiving placebo (N= 58) twice daily for a 24-month period. The linear functions are estimated values based on hierarchical regression analyses of the data provided by the participants in this randomized trial, all of whom had breast cancer in remission.

 


View larger version (11K):

[in a new window]
 
Fig. 2. Relationship between SHBG assessed at 24 months post-baseline and trait anxiety (assessed at baseline) for women receiving 10 mg of tamoxifen (N= 59) and women receiving placebo (N= 58) twice daily for a 24-month period. The linear functions are estimated values based on hierarchical regression analyses of the data provided by the participants in this randomized trial, all of whom had breast cancer in remission.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Psychosomatic Society